Technical Analysis for GTXI - GTx, Inc.

Grade Last Price % Change Price Change
grade F 0.96 -0.02% 0.00
GTXI closed down 0.02 percent on Friday, January 18, 2019, on 21 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical GTXI trend table...

Date Alert Name Type % Chg
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Narrow Range Bar Range Contraction -0.02%
Jan 17 NR7 Range Contraction -0.02%
Jan 17 Wide Bands Range Expansion -0.02%
Jan 16 Inside Day Range Contraction 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 15 20 DMA Support Bullish -1.03%
Jan 15 Wide Bands Range Expansion -1.03%
Jan 14 New Downtrend Bearish 1.05%

Older signals for GTXI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. It is involved in developing Enobosarm, an androgen receptor modulator, which is in Phase III clinical trials for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer in the United States, Europe, Russia, and South America. The company also develops Capesaris, an oral nonsteroidal estrogen receptor alpha agonist that is in Phase II clinical trial for secondary hormonal therapy in men with metastatic castration resistant prostate cancer. In addition, its preclinical development stage products include inhibitors of steroid biosynthetic enzymes, anticancer therapies, estrogen receptor beta agonists, and other novel compounds for the potential treatment of cancer, metabolic diseases, ophthalmic diseases, psoriasis, and pain. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.
Is GTXI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.6
52 Week Low 0.74
Average Volume 440,499
200-Day Moving Average 11.44
50-Day Moving Average 1.1949
20-Day Moving Average 0.9053
10-Day Moving Average 0.9751
Average True Range 0.1047
ADX 23.11
+DI 16.5153
-DI 20.837
Chandelier Exit (Long, 3 ATRs ) 0.8659
Chandelier Exit (Short, 3 ATRs ) 1.0541
Upper Bollinger Band 1.0846
Lower Bollinger Band 0.726
Percent B (%b) 0.65
BandWidth 39.611179
MACD Line -0.0929
MACD Signal Line -0.1359
MACD Histogram 0.043
Fundamentals Value
Market Cap 15.42 Million
Num Shares 16.1 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -0.56
Price-to-Sales 0.00
Price-to-Book 14.80
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.02
Resistance 3 (R3) 1.02 0.99 1.01
Resistance 2 (R2) 0.99 0.98 1.00 1.01
Resistance 1 (R1) 0.98 0.97 0.97 0.98 1.00
Pivot Point 0.95 0.95 0.95 0.96 0.95
Support 1 (S1) 0.94 0.94 0.93 0.94 0.92
Support 2 (S2) 0.91 0.93 0.92 0.91
Support 3 (S3) 0.90 0.91 0.91
Support 4 (S4) 0.90